超声微泡淋巴管定位在淋巴管静脉吻合术治疗淋巴水肿前的应用
本研究为单中心回顾性分析,纳入11例乳腺癌治疗后继发性上肢淋巴水肿女性患者,术前经皮内注射微泡行对比增强超声定位目标淋巴管,并与吲哚菁绿荧光淋巴管造影比较。对比增强超声在所有患者中均有助于识别淋巴管,包括6例吲哚菁绿无法进行或未能识别目标者,作者认为其是颇有前景的定位工具。
要点
- 对比增强超声在全部11例患者中均有助于识别淋巴管,包括6例吲哚菁绿荧光淋巴管造影无法进行或未识别出目标者。
- 24个吻合中33%由对比增强超声与吲哚菁绿共同定位,58%仅由对比增强超声定位,8%仅由吲哚菁绿定位。
- 对比增强超声定位目标的33处探查中22处完成吻合,技术成功率为67%。
核心结论
- 对比增强超声是识别上肢淋巴管的颇有前景的工具,尤其适用于吲哚菁绿荧光淋巴管造影未能显示目标或无法使用的情况。
研究设计与样本
- 单中心回顾性研究,2019年10月至2021年9月于淋巴管静脉吻合术前对上肢继发性淋巴水肿患者行经皮内注射微泡的对比增强超声检查。
- 共纳入11例乳腺癌治疗后继发性上肢淋巴水肿女性患者,平均年龄56岁±8(标准差)。
- 以吲哚菁绿荧光淋巴管造影为参考标准进行对比,技术成功率定义为对比增强超声识别淋巴管并成功完成淋巴管静脉吻合。
- 采用描述性统计。
诊断标准与关键数值
- 技术成功率定义为对比增强超声识别出淋巴管并成功完成淋巴管静脉吻合。
- 对比增强超声定位目标的33处探查中22处完成吻合,技术成功率为67%。
- 24个吻合中,8个(33%)由对比增强超声与吲哚菁绿荧光淋巴管造影共同定位,14个(58%)仅由对比增强超声定位,2个(8%)仅由吲哚菁绿荧光淋巴管造影定位。
临床应用与阅片要点
- 术前经皮内注射微泡行对比增强超声可识别上肢淋巴管,微泡注射部位中位数为11处(范围8-14处)。
- 共行35处探查(每例中位3处,范围2-4处),完成24个淋巴管静脉吻合(每例中位3个,范围0-4个)。
- 7例女性因使用对比增强超声而至少额外完成1个淋巴管静脉吻合。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Lymphaticovenous anastomosis (LVA) surgery is an effective surgical treatment of secondary lymphedema in the extremities, but indocyanine green (ICG) fluorescent lymphography, the reference standard for imaging target lymphatic vessels, has several limitations. More effective methods are needed for preoperative planning. Purpose To evaluate whether contrast-enhanced US (CEUS) can be used to identify target lymphatic vessels for LVA surgery in patients with secondary upper extremity lymphedema and compare the results with those from ICG fluorescent lymphography. Materials and Methods In this single-center retrospective review, CEUS with intradermal injection of microbubbles was performed in patients before LVA surgery in the upper extremities between October 2019 and September 2021. All patients had secondary upper extremity lymphedema from breast cancer treatment. Technical success rate was defined as lymphatic vessels identified with use of CEUS that led to successful LVAs. Descriptive statistics were used. Results All 11 patients were women (mean age, 56 years ± 8 [SD]). The median number of microbubble injection sites was 11 (range, 8-14). CEUS helped identify lymphatic vessels in all 11 women, including in six women in whom ICG fluorescent lymphography could not be performed or failed to help identify any targets. Thirty-five explorations (median, three per patient; range, two to four) were performed, and 24 LVAs (median, three per patient; range, zero to four) were created. Of the anastomoses, 33% (eight of 24) were mapped with use of both CEUS and ICG fluorescent lymphography, 58% (14 of 24) with CEUS only, and 8% (two of 24) with ICG fluorescent lymphography only. Among the 33 explorations on targets mapped with CEUS, an anastomosis could be made at 22 sites, for a technical success rate of 67%. Seven women had at least one additional LVA created from the use of CEUS. Conclusion Contrast-enhanced US is a promising tool for identifying lymphatic vessels in the upper extremities, especially when indocyanine green fluorescent lymphography fails to depict targets or cannot be used. Published under a CC BY 4.0 license.
引用
- Jang, Lee, Hesley, et al. Lymphatic Mapping Using US Microbubbles before Lymphaticovenous Anastomosis Surgery for Lymphedema. Radiology. 2022. PMID: 35380494. doi:10.1148/radiol.212351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。